BIVALENT TICK FEVER VACCINE
국가: 오스트레일리아
언어: 영어
출처: APVMA (Australian Pesticides and Veterinary Medicines Authority)
환자 정보 전단 유효 성분:
BABESIA BOVIS; ANAPLASMA CENTRALE
제공처:
DEPARTMENT OF AGRICULTURE AND FISHERIES
INN (International Name):
Anaplasma centrale(10000000u/dose)+Babesia bovis(10000000u/dose)
약제 형태:
MISC. VACCINES OR ANTI SERA
구성:
BABESIA BOVIS VACCINE-MICROBIAL Active 0.0 P; ANAPLASMA CENTRALE VACCINE-VIRAL Active 0.0 P
패키지 단위:
20mL-200mL
수업:
VP - Veterinary Pesticide
Manufactured by:
DEPT AGRICULTURE, FI
치료 그룹:
CATTLE | BEEF | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CALF | COW | DAIRY COW | HEIFER | STEER
치료 영역:
IMMUNOTHERAPY
치료 징후:
TICK FEVER - BOVINE ANAPLASMOSIS | TICK FEVER - BOVINE BABESIOSIS | VACCINE | ANAPLASMA MARGINALE | BABESIA BIGEMINA | BABESIA BOVIS | EQUINE ROTAVIRUS | RED WATER | REDWATER
제품 요약:
Poison schedule: 0; Withholding period: WHP: Nil; Host/pest details: CATTLE: [TICK FEVER - BOVINE ANAPLASMOSIS, TICK FEVER - BOVINE BABESIOSIS, VACCINE]; For control of tick fever (Babesiosis & Anaplasmosis) in cattle.This product is contraindicated for use in cattle during late pregnancy. Caution: Avoid carcass damage. See PRECAUTIONS, etc. on label also.
승인 상태:
Registered
승인 날짜:
2023-07-01
환자 정보 전단
FOR ANIMAL TREATMENT ONLY
_BIVALENT TICK FEVER VACCINE_
_Contains B bovis 1 x 10_
_7_
_,_
_A centrale 1 x 10_
_7_
_ organisms per dose_
FOR CONTROL OF TICK FEVER IN CATTLE
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT
If accidental self-injection occurs, seek medical advice
Dose: 2mL. For subcutaneous or intramuscular injection
WITHHOLDING PERIOD NIL
EXPIRY DATE:
B
Store between 2°C to 8°C (Refrigerate. DO NOT FREEZE)
Tick Fever Centre,
280 Grindle Rd, Wacol, QLD 4076
File name
49715_
20-200mL_immediate_MPL_V02.pdf
Dimensions
95mm X 50mm
Scale
100%
Date
21/05/08 V02
APVMA
49715/20–200mL/0508
20–200mL
BIV 010–100
PANTONE 288
PANTONE 285
PANTONE 1505
4507 _6
6
APPROVED
LABEL
Info
PEST
Verified
FOR ANIMAL TREATMENT ONLY
BIVALENT TICK FEVER VACCINE
BIVALENT VACCINE CONTAINS:
_BABESIA BOVIS_ 1 X 10
7 ORGANISMS PER DOSE
_ANAPLASMA CENTRALE_ 1 X 10
7 ORGANISMS PER DOSE
FOR CONTROL OF TICK FEVER (BABESIOSIS
AND ANAPLASMOSIS) IN CATTLE
This vaccine contains live attenuated strains of tick fever
organisms. One vaccination is usually sufficient to provide
life long immunity against natural tick fever infections.
Immunity to both parasites develops within 8 weeks of
administration of the vaccine.
_This vaccine is registered with the Australian Pesticides _
_and Veterinary Medicines Authority (Reg. No 49715) _
_and is manufactured in compliance with the Australian _
_Code of Good Manufacturing Practice for Veterinary _
_Preparations._
TICK FEVER CENTRE
280 GRINDLE RD.,
WACOL, QLD 4076, AUSTRALIA
TELEPHONE: (07) 3898 9655
FAX NO: (07) 3898 9685
E-MAIL: TFC@DPI.QLD.GOV.AU
DIRECTIONS FOR USE
Restrictions apply on the use of imidocarb in lactating
dairy cattle.
Restrictions also apply to the supply of oxytetracycline; contact
a veterinarian if this drug is to be used.
AFTER CARE
Cattle should have access to good feed, shade and water
during and after the expected reaction periods. Stress should
be avoided.
WITHHOLDING PERIOD
Nil; however, carcass quality could be affected by fever if
animals are slaughtered during
전체 문서 읽기
제품 특성 요약
_TICK FEVER CENTRE, WACOL _
_MSDS BIVALENT _
MATERIAL SAFETY DATA SHEET
BIVALENT TICK FEVER VACCINE
_REF: MSDS 2 _
_ _
_ _
Rev: 6
Date of Issue: 4/09/08
Page 1 of 5
Department of Primary Industries and Fisheries, Queensland
Biosecurity
Tick Fever Centre
280 Grindle Road, Wacol Queensland 4076 Australia
Telephone: +61 7 3898 9655
Fax: +61 7 3898 9685
E-mail:
tfc@dpi.qld.gov.au
Web-site: http://www.dpi.qld.gov.au/tickfever/
IDENTIFICATION
PRODUCT NAME
:
BIVALENT
TICK FEVER VACCINE
OTHER NAMES:
Bivalent chilled vaccine
MANUFACTURER’S PRODUCT CODE
:
BIV/10, 20, 25, 50, 100.
UN
NUMBER:
None allocated
DANGEROUS GOODS CLASS AND
None allocated, no subsidiary risk
SUBSIDIARY RISK
HAZCHEM CODE:
None allocated
POISONS SCHEDULE NUMBER:
Not scheduled
USE:
For control of Tick Fever (Bovine Babesiosis and
Anaplasmosis) by vaccination in cattle.
PHYSICAL DESCRIPTION/PROPERTIES:
APPEARANCE:
Liquid blood based vaccine packed in polypropylene
pillow
packs
BOILING
POINT
No data. Expected to be about 100
0
C
VAPOUR PRESSURE:
No data
SPECIFIC GRAVITY:
Approximately 0.97
FLAMMABILITY: Does not burn
CORROSIVENESS: Not corrosive
_TICK FEVER CENTRE, WACOL _
_MSDS BIVALENT _
MATERIAL SAFETY DATA SHEET
BIVALENT TICK FEVER VACCINE
_REF: MSDS 2 _
_ _
_ _
Rev: 6
Date of Issue: 4/09/08
Page 2 of 5
OTHER PROPERTIES:
INGREDIENTS:
Contains live attenuated tick fever organisms (_Babesia bovis_
_and Anaplasma centrale_) in bovine blood diluted with a cell
free diluent. The diluent consists of 10% bovine serum in an
isotonic balanced salt solution.
Each
2
mL
dose
of
bivalent vaccine contains:
(i)
Mixed
전체 문서 읽기
